Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 24/10/19961 min de lecture
Guidant Corp.; Premarket Approval of SELUTERegister Steroid Eluting Endocardial Lead Models 4185 and 4285
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its approval of the application by Guidant Corp., St. Paul, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of May 8, 1996, of the approval of the application.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →